Daohong Zhou
Associate Director & Professor - Drug Development & Center for Innovative Discovery The University of Texas Health Science Center at Houston (UTHealth Houston)
Seminars
Tuesday 28th October 2025
Pre-Clinical & Clinical Development of DT-2216, A Selective & Potent BCL-XL Degrader for Cancer Therapy
2:30 pm
